Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Claude Dionet"'
Autor:
Emmanuel Chautard, Claude Dionet, Pierre Verrelle, Dietrich Averbeck, Bruno Pereira, Geoffroy Marceau, Mélanie Müller-Barthélémy, Andrei Tchirkov, John Gueulette, Jean-Marc Denis, Vincent Sapin
Publikováno v:
International Journal of Radiation Biology
International Journal of Radiation Biology, 2016, 92 (9), pp.527-35. ⟨10.1080/09553002.2016.1186300⟩
International Journal of Radiation Biology, Informa Healthcare, 2016, 92 (9), pp.527-35. ⟨10.1080/09553002.2016.1186300⟩
International Journal of Radiation Biology, 2016, 92 (9), pp.527-35. ⟨10.1080/09553002.2016.1186300⟩
International Journal of Radiation Biology, Informa Healthcare, 2016, 92 (9), pp.527-35. ⟨10.1080/09553002.2016.1186300⟩
International audience; Purpose: To analyze the dose rate influence in hyper-radiosensitivity (HRS) of human melanoma cells to very low doses of fast neutrons and to compare to the behaviour of normal human skin fibroblasts.Materials and methods: We
Autor:
Andrei Tchirkov, Veronique Bodez, Maryse Rapp, Jack Arnold, Marie-Laure Nénot, Claude Dionet, Pierre Verrelle, Sylvain Crespin, Jean-Pierre Alard
Publikováno v:
Radiation Research
Radiation Research, Radiation Research Society, 2002, 158, pp.650-656
Radiation Research, 2002, 158, pp.650-656
Radiation Research, Radiation Research Society, 2002, 158, pp.650-656
Radiation Research, 2002, 158, pp.650-656
We recently reported that the exposure of cancer cells to 14 MeV neutrons at a very low dose rate (0.8 mGy min(-1)) produced a marked increase in cell killing at 5 cGy, followed by a plateau in survival and chromosomal damage. Simulation of the energ
Autor:
Didier Blaise, Dominique Maraninchi, Philippe Chollet, J. Fleury, J. P. Lamagnere, Philippe Travade, Patrice Viens, R. Plagne, Claude Linassier, Michel Legros, Claude Dionet, Philippe Colombat, Jacques Tortochaux, Hervé Curé
Publikováno v:
Leukemia & Lymphoma. 20:259-266
We report the experience of three French centres which evaluated high-dose therapy (HDT) as consolidation therapy for poor prognosis Hodgkin's disease (HD). From March 1986 to April 1990, 23 consecutive patients with poor prognosis stage IV HD underw
Autor:
R. Plagne, Philippe Chollet, Claude Dionet, Ernest Belembaogo, Françoise Tavernier, Jacques Tortochaux, Hervé Curé, Michel Legros, Philippe Travade, J. Fleury, Fabrice Kwiatkowski, Paule Condat
Publikováno v:
Leukemia & Lymphoma. 15:419-432
Most patients with Hodgkin's disease (HD) are cured with chemotherapy and/or radiotherapy. However, half of those with advanced stage disease (IIIB, IV) do not respond adequately to treatment or relapse. Salvage therapy used in such cases gives from
Autor:
J. P. Alard, Pierre Verrelle, Ziad Francis, Andrei Tchirkov, Maryse Rapp, Claude Dionet, Jack Arnold
Publikováno v:
Radioprotection
Radioprotection, 2006, 41, pp.S121-S130. ⟨10.1051/radiopro:2007019⟩
Radioprotection, EDP Sciences, 2006, 41, pp.S121-S130. ⟨10.1051/radiopro:2007019⟩
Radioprotection, 2006, 41, pp.S121-S130. ⟨10.1051/radiopro:2007019⟩
Radioprotection, EDP Sciences, 2006, 41, pp.S121-S130. ⟨10.1051/radiopro:2007019⟩
Radiobiology with fast neutrons. Human melanoma cells particularly resistant to high energy X rays were irradiated with 14 MeV neutrons at low doses ranging from 5 cGy to 1.12 Gy and using two different dose rates: a very low one (0.8 mGy mn -1 ) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beadeea663ad6576b0c334808f305cbe
https://hal.in2p3.fr/in2p3-00172093/document
https://hal.in2p3.fr/in2p3-00172093/document
Autor:
Veronique Bodez, M. L. Nénot, Maryse Rapp, Andrei Tchirkov, H. Meunier, J. P. Alard, Jack Arnold, Pierre Verrelle, Claude Dionet
Publikováno v:
Radiation Protection Dosimetry
Radiation Protection Dosimetry, Oxford University Press (OUP), 2002, 99, pp.47-48
Radiation Protection Dosimetry, 2002, 99, pp.47-48
Radiation Protection Dosimetry, Oxford University Press (OUP), 2002, 99, pp.47-48
Radiation Protection Dosimetry, 2002, 99, pp.47-48
The structure of the survival curve of melanoma cells irradiated by 14 MeV neutrons displays unusual features at very low dose rate where a marked increase in cell killings at 0.05 Gy is followed by a plateau for survival from 0.1 to 0.32 Gy. In para
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7faa462267aa7f103f8bed19f51a74ef
http://hal.in2p3.fr/in2p3-00012049
http://hal.in2p3.fr/in2p3-00012049
Autor:
Jean-Claude Tamain, Jean Pierre Alard, Paul Malet, Andrei Tchirkov, Annie Veyre, Denise Donnarieix, Isabelle Monbel, Claude Dionet, Veronique Bodez, Joël Dhermain, Fabrice Kwiatkowski, Pierre Verrelle, Maryse Rapp, Jack Arnold
Publikováno v:
Radiation Research
Radiation Research, 2000, 154, pp.406-411
Radiation Research, Radiation Research Society, 2000, 154, pp.406-411
Radiation Research, 2000, 154, pp.406-411
Radiation Research, Radiation Research Society, 2000, 154, pp.406-411
Human melanoma cells that are resistant to gamma rays were irradiated with 14 MeV neutrons given at low doses ranging from 5 cGy to 1.12 Gy at a very low dose rate of 0.8 mGy min(-1) or a moderate dose rate of 40 mGy min(-1). The biological effects o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a497674e1f063dee5887e16d9bce4875
https://hal.in2p3.fr/in2p3-00012154
https://hal.in2p3.fr/in2p3-00012154
Autor:
R. Plagne, Jacques Chassagne, Claude Dionet, Pierre Verrelle, Meissonnier Frédéric, Fabrice Kwiatkowski, Yvette Fonck, V. Feillel
Publikováno v:
Journal of the National Cancer Institute. 83(2)
In 20 women with breast carcinoma, 17 of whom had locally advanced cancer and 3 of whom had confirmed metastases, the expression of P-glycoprotein was evaluated before the start of a chemotherapy regimen that included multidrug resistance-related dru
Publikováno v:
Lung Cancer. 5:20